tm
Seeing Is Believing
tm
Seeing Is Believing
CYTH is currently covered by 1 analysts
Cyclo Therapeutics's activity chart (see below) currently has 1 price targets and 4 ratings on display. The stock rating distribution of CYTH is 33.33% HOLD and 66.67% BUY.
Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 49 days.
Highest price target for CYTH is $1, Lowest price target is $1.
Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 27-Aug-2024. First documented stock forecast 17-Dec-2020.
Currently out of the existing stock ratings of CYTH, 1 are a HOLD (33.33%), 2 are a BUY (66.67%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$4
2 years 1 months ago
(27-Aug-2024)
1/2 (50%)
$2.6 (185.71%)
49
What is CYTH (Cyclo Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on CYTH (Cyclo Therapeutics)?
Which analyst has the most public recommendations on CYTH (Cyclo Therapeutics)?
Which analyst is the currently most bullish on CYTH (Cyclo Therapeutics)?
